Skinbetter science was formed in 2016 to establish a new biotech-based paradigm in skincare. Their innovative approach is built on three pillars: a technology pipeline of scientific innovation across multiple skincare categories, rigorous clinical substantiation of the safety and efficacy of the products developed from these novel technologies, and a partnership with dermatologists, plastic surgeons, and other healthcare professionals in the aesthetic medical community to deliver best-in-class skincare solutions to their patients.

Prior to establishing skinbetter science, the Founders developed and honed this biotech-based aesthetic philosophy throughout decades of experience founding and building Medicis Pharmaceutical Corporation from 1998-2012 into one of the leading specialty pharmaceutical companies in the world in both medical dermatology and aesthetic medicine – with signature accomplishments including the launch in the US and Canada of multiple iconic drugs, devices, and biologics such as Restylane®, Dysport®, and Solodyn®.

At skinbetter science, the leadership’s rich heritage in dermatologic and aesthetic medicine informs their entire approach to identifying unmet skincare needs in the market, discovering and developing breakthrough technologies to address those needs, and researching and testing these breakthroughs to the highest standards of clinical and scientific validation. This commitment to advancing patient care through the study of skincare science remains at the core of their brand.